EUVIMEDEUVIMED entdecken
Crossref

Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment

Katsiaryna Laryionava, Mechthild Hartmann, Halina Sklenarova, Pia Heussner, Matthias Villalobos, Dirk Jäger, Eva C Winkler

Oncology Research and Treatment · 2019 · 42 (9) · 458-465

DOI: 10.1159/000501129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research and Treatment, online erschienen am 10.07.2019. Verfasst von Katsiaryna Laryionava und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany. Hauptthemen laut MEDLINE: Communication, Longevity, Physician-Patient Relations, Quality of Life. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer patients often face decisions whether to proceed with cancer-specific treatment or to switch to best supportive care. In these decisions, patients’ preferences should be determining cornerstones. The aim of this survey was to elicit patients’ preferences regarding discussions about forgoing treatment and factors influencing their preferences.

Methods

We surveyed 194 patients at the National Center for Tumor Diseases, Germany. Quality of life (FACT-G), cancer-specific distress (QSC-R10), anxiety/depression (PHQ-4/GAD-2), preferences regarding quality/length of life (QQ), patient-physician communication (CARES-SF), and family role (CCAT-P) were assessed.

Results

Patients weighting quality of life over lifetime wanted their oncologists to address treatment limitations as early as possible (p = 0.00). Patients striving for a longer lifetime did not want such discussions (p = 0.05). Having discussed treatment limitations was not associated with increased anxiety, depression, or distress. Limiting treatment was discussed only with one-third of the patients with a prognosis of less than 6 months and rather with elderly patients or patients in a worse medical condition. Attributing an important role to family decisions was associated with striving for lifetime (p = 0.01).

Conclusion

Preferences for either quality or length of life were associated with patients’ willingness to discuss forgoing cancer-specific treatment. Timely discussion of realistic treatment goals is one way to avoid overtreatment. Patients striving for lifetime require increased attention and opportunities to address prognosis and risks of treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CommunicationLongevityPhysician-Patient RelationsQuality of LifeAgedAmbulatory CareAnxietyCross-Sectional StudiesDepressionFamilyFemaleGermanyHumansMaleMiddle AgedNeoplasmsOncologistsPatient PreferencePrognosisSurveys and Questionnaires

Stichwörter der Autor:innen

CommunicationForgoing treatmentLength of lifePatients’ preferencesQuality of life

Autor:innen und Institutionen

  • Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Program for Ethics and Patient-Oriented Care in Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany.
  • Hospital for Forensic Psychiatry, District Hospital Ansbach, Ansbach, Germany.
  • Oncological Center Oberland, Department of Psycho-Oncology, Hospital Garmisch-Partenkirchen, Garmisch-Partenkirchen, Germany.
  • Department of Thoracic Oncology, University Hospital Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany.

Zitieren

APA

Laryionava, K., Hartmann, M., Sklenarova, H., Heussner, P., Villalobos, M., Jäger, D., & Winkler, E. C. (2019). Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment. Oncology Research and Treatment, 42(9), 458-465. https://doi.org/10.1159/000501129

Vancouver

Laryionava K, Hartmann M, Sklenarova H, Heussner P, Villalobos M, Jäger D, et al. Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment. Oncology Research and Treatment. 2019;42(9):458-465. doi:10.1159/000501129

BibTeX
@article{Laryionava2019,
  author = {Laryionava, Katsiaryna and Hartmann, Mechthild and Sklenarova, Halina and Heussner, Pia and Villalobos, Matthias and Jäger, Dirk and Winkler, Eva C},
  title = {Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment},
  journal = {Oncology Research and Treatment},
  year = {2019},
  volume = {42},
  number = {9},
  pages = {458--465},
  doi = {10.1159/000501129}
}
Kostenlos starten →